Fiona Theunissen is leading the advocacy and communications activities on a multi-country maternal health project which aims to reduce maternal deaths from postpartum haemorrhage.  Working with the WHO, MSD for Mothers and Ferring Pharmaceuticals, Concept Foundation is working to ensure affordable, quality manufacture and supply of heat-stable carbetocin, an alternative to existing uterotonics for the prevention of PPH, for low and low-middle income countries.

Fiona has an extensive program management, advocacy, communications and technology transfer background in the health sector working with governments, civil society and the private sector to expand access to treatment for multidrug-resistant tuberculosis (MDR-TB) in India, China, Russia and South Africa, providing services for cancer patients and contributing to the expansion of midwifery services in low income countries.

Fiona holds an MBA in International Organizations from the University of Geneva and is the mother of two young children.